Resultados de la búsqueda 121-130 of 1656 for Secondary

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  2. Hipertensión secundaria - Médicos y departamentos - Mayo Clinic

    Obtén más información acerca de la hipertensión arterial provocada por otra afección médica. Infórmate sobre los factores de riesgo y tratamientos para ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme (GBM) which often displays the ...

  6. Hemocromatosis - Síntomas y causas - Mayo Clinic

    Causes of secondary or acquired iron overload · Neonatal hemochromatosis is a serious disease where iron builds up quickly in the liver of a baby while in the ...

  7. Radiología - Ensayos clínicos - Mayo Clinic

    ... secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient selection factors and processes ...

  8. Radiología - Ensayos clínicos - Mayo Clinic

    ... secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient selection factors and processes ...

  9. Radiología - Ensayos clínicos - Mayo Clinic

    ... secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient selection factors and processes ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Secondary Goals. To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC ...